title: Management of acquired coagulation disorders in emergency and intensive-care medicine.
abstract: Coagulation disorders usually confront the emergency physician as bleeding episodes or as abnormalities of laboratory tests. Bleeding has to be treated aggressively, while pathological coagulation tests should be related to a more differentiated diagnosis at first. The most common causes of acquired coagulation disorders are liver disease, vitamin K deficiency, and disseminated intravascular coagulation (DIC). More rarely, inhibitors, external factors such as drugs or extracorporeal circulation, or other diseases such as amyloidosis are present. Since localized hemorrhage is the most common bleeding source in liver disease, endoscopic and surgical therapeutic measures, respectively, are warranted. Careful and balanced substitution therapy according to laboratory findings should be initiated simultaneously and should consist of fresh frozen plasma (FFP), which contains all components of the coagulation system physiologically balanced. Prothrombin complex concentrates should be used in emergency situations only, keeping their potential hazards in mind. Adequate vitamin K substitution is indicated in liver disease as well as in coagulopathy due to vitamin K deficiency. Management of DIC primarily consists of aggressive treatment of the underlying disease. Substitution therapy is difficult and should be carefully monitored by the adequate laboratory tests. FFP is the adequate source of both procoagulants and inhibitors but may cause certain problems. Heparin therapy can be beneficial but is not recommended generally. Antithrombin III substitution cannot be assumed as established therapy so far. Inhibitors can lead to bleeding, but the most common inhibitor, lupus anticoagulant, rather predisposes to thrombosis. In bleeding patients with inhibitors against single clotting factors, treatment consists of adequate substitution before initiating the diagnostic workup.
authors.affiliation: Department of Internal Medicine I, University of Vienna, Medical School, Austria.
authors.forename: T
authors.initials: T
authors.lastname: Staudinger
authors.forename: G J
authors.initials: GJ
authors.lastname: Locker
authors.forename: M
authors.initials: M
authors.lastname: Frass
mesh_terms: D000925:Anticoagulants / Q000378:metabolism; D001323:Autoantibodies / Q000097:blood; D001778:Blood Coagulation Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D003422:Critical Care; D004211:Disseminated Intravascular Coagulation / Q000628:therapy; D004632:Emergency Medical Services; D006801:Humans; D008107:Liver Diseases / Q000209:etiology / Q000628:therapy; D014813:Vitamin K Deficiency / Q000628:therapy
chemical_list: D000925:Anticoagulants; D001323:Autoantibodies